News & Analysis as of August 29, 2025

Pharmaceutical Industry

+ Follow

Read guidance, analysis, and updates on the myriad issues arising from the global response to the COVID-19 pandemic. Updated hourly every day, the insights published here are written by leading lawyers and law firms helping to make sense of insurance, employment, tax, securities, M&A, risk management, and every other consideration touched by this crisis. Follow the channel for a daily email brief of the latest and best updates. less -

European Commission Approves Moderna’s Updated COVID-19 Vaccine

Goodwin on 8/19/2025

On July 30, 2025, Moderna announced that the European Commission (EC) granted marketing authorization for the updated formulation of Moderna’s COVID-19 vaccine Spikevax®. The updated vaccine targets the LP.8.1 variant of...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 98

Jones Day on 3/22/2023

This regular update (no. 98 | 1 March 2023) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 86

Jones Day on 9/26/2022

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. ...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 80

Jones Day on 4/28/2022

COMPETITION & STATE AID - State Aid - European Commission adopts Temporary Crisis Framework to support economy in context of Russia's invasion of Ukraine - On 23 March 2022, the Commission adopted a Communication on a...more

Covid-19 Key EU Developments, Policy & Regulatory Update No. 78

Jones Day on 3/24/2022

COMPETITION & STATE AID - State Aid - European Commission publishes first Report on implementation of Recovery and Resilience Facility - On 1 March 2022, the Commission published its first Report to the European...more

COVID-19 Key EU Developments, Policy & Regulatory Update No.72

Jones Day on 1/20/2022

COMPETITION & STATE AID - Competition- European Commission expresses views on IAG’s (aborted) intended acquisition of Air Europa, including in light of impact of COVID-19 restrictions - On 16 December 2021, the...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 71

Jones Day on 1/6/2022

COMPETITION & STATE AID - Competition - Executive Vice President and Competition Commissioner Margrethe Vestager speaks at U.S. Chamber of Commerce's Transatlantic Business Works Summit. ...more

COVID-19 KEY EU Developments, Policy & Regulatory Update No. 70

Jones Day on 12/15/2021

COMPETITION & STATE AID - State Aid - European Commission adopts revised Guidelines on State aid to promote risk finance investments- On 6 December 2021, the Commission published its Communication on Guidelines on...more

COVID-19 Key EU Developments, Policy & Regulatory Update No.69

Jones Day on 12/9/2021

COMPETITION & STATE AID - State Aid - European Commission publishes revised Communication on State aid rules for Important Projects of Common European Interest (IPCEI). On 25 November 2021, the Commission published a...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 68

Jones Day on 12/3/2021

COMPETION & STATE AID - European Commission adopts Communication on a Competition Policy Fit for New Challenges - On 18 November 2021, the European Commission adopted a Communication on a Competition Policy Fit for New...more

International News: Healthcare - Spotlight on the Industry - May 2021

McDermott Will & Schulte on 5/5/2021

Sovereign Wealth Fund Investment in the Global Healthcare Industry - Sovereign Wealth Funds (SWF) seek out investments that are resilient, conducive to their aims and objectives, and reasonably free from market...more

Brussels Regulatory Brief: February 2021

K&L Gates LLP on 3/12/2021

ANTITRUST AND COMPETITION - The European Commission Accepts Commitments from a Pharma Company to Stop Its Excessive Prices - On 15 May 2017, the European Commission (Commission) announced that it had opened formal proceedings...more

EU Imposes Authorization Requirements for COVID-19 Vaccine Exports

Morgan Lewis on 2/4/2021

In response to delayed EU shipments of certain COVID-19 vaccines to the European Union, the European Commission (Commission) passed on 29 January 2021 Regulation 2021/111 (Export Authorization Regulation) which is in force...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells on 12/8/2020

In Tuesday's Report: European Commission proposes far-reaching pharmaceutical strategic plan, Biden names health care nominees, and warnings over Christmas COVID-19 spread....more

Increasing Scrutiny of Foreign Investments in the German Healthcare Sector

White & Case LLP on 6/3/2020

The COVID-19 pandemic has changed most governments' views on the strategic relevance of the domestic healthcare sectors across the globe. Although the European Commission, and also the German government, have re-emphasized...more

International News: COVID-19 Global Pandemic - May 2020

McDermott Will & Schulte on 5/27/2020

The Legal Impact in Europe on Pharmaceutical and Medical Device Companies - The current crisis mode has triggered legal and commercial issues that affect the pharmaceutical and medical device industry across Europe. ...more

COVID-19: The Return of the ‘Comfort Letter’

Morgan Lewis on 5/4/2020

The European Commission published its first comfort letter in nearly 20 years on April 29, in an effort to foster cooperation among businesses during the coronavirus (COVID-19) pandemic. ...more

An update on cooperation in the life sciences industry: the European Commission’s framework for sending “comfort letters” on...

Hogan Lovells on 4/16/2020

The European Commission has published a Temporary Framework Communication to provide guidance to companies that are cooperating to ensure the supply and distribution of essential products – including medicines and medical...more

New European Commission's guidance document on medical devices and IVDs in the COVID-19 context

Hogan Lovells on 4/11/2020

On 3 April 2020, the European Commission issued a guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices ("IVD") in the COVID-19 context....more

COVID-19: European Commission Details Plans to Postpone EU Medical Device Regulation and European Derogation Procedure to Get...

K&L Gates LLP on 4/10/2020

The European Commission (EC) has published details of its proposal to postpone the application date of the Medical Devices Regulation (MDR) for one year. In addition, the EC proposes introducing a new procedure to address...more

COVID-19- European Commission's recommendation on conformity assessment and market surveillance procedures

Hogan Lovells on 3/18/2020

On 16 March 2020, the European Commission published Recommendation (EU) 2020/403 of 13 March on conformity assessment and market surveillance procedures within the context of the COVID-19 threat. The objective of the...more

21 Results

View per page

Page: of 1

Coronavirus/COVID-19 › European Commission › Pharmaceutical Industry

"My best business intelligence, in one easy email…"